These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 30686359)

  • 1. [Not Available].
    Pinturaud M; Vasseur M; Odou P
    Bull Cancer; 2018 Dec; 105 Suppl 2():S205-S213. PubMed ID: 30686359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Not Available].
    Gauthier J
    Bull Cancer; 2018 Dec; 105 Suppl 2():S214-S217. PubMed ID: 30686360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Not Available].
    Rubio MT; Galaine J; Borg C; Daguindau É
    Bull Cancer; 2018 Dec; 105 Suppl 2():S135-S146. PubMed ID: 30686352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Not Available].
    Le Bourgeois A
    Bull Cancer; 2018 Dec; 105 Suppl 2():S188-S197. PubMed ID: 30686357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Not Available].
    Chabannon C; Larghero J
    Bull Cancer; 2018 Dec; 105 Suppl 2():S198-S204. PubMed ID: 30686358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Not Available].
    Rahal I; Cabannes-Hamy A; Boissel N
    Bull Cancer; 2018 Dec; 105 Suppl 2():S158-S167. PubMed ID: 30686354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Not Available].
    Salles G; Sesques P; Ferrant E; Safar V; Ghesquieres H; Bachy E
    Bull Cancer; 2018 Dec; 105 Suppl 2():S168-S177. PubMed ID: 30686355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Not Available].
    Dourthe MÉ; Yakouben K; Chaillou D; Lesprit E; Dalle JH; Baruchel A
    Bull Cancer; 2018 Dec; 105 Suppl 2():S147-S157. PubMed ID: 30686353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Not Available].
    Alcazer V; Delenda C; Poirot L; Depil S
    Bull Cancer; 2018 Dec; 105 Suppl 2():S178-S187. PubMed ID: 30686356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality risk management of the chimeric antigen receptor T cell pharmaceutical circuit in one of the first qualified European centers.
    Talarmin C; Kerob S; Cartier F; Madelaine I; Mukenyi S; Schwartz E; Boissel N; Baruchel A; Thieblemont C; Parquet N; Brignier A; Lesprit E; Desproges A; Magdelonnette L; Larghero J; Mebarki M
    Cytotherapy; 2020 Dec; 22(12):792-801. PubMed ID: 32732084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [CAR-T cells gene therapy medicines: Regulatory status and pharmaceutical circuits in Europe and France].
    de Jorna R; Madelaine I; Larghero J; Mebarki M
    Bull Cancer; 2021 Oct; 108(10S):S162-S167. PubMed ID: 34920799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hospital pharmacist's roles and responsibilities with CAR-T medicines.
    Moreno-Martínez ME; Vinent-Genestar J; Muñoz-Sánchez C; Carreras-Soler MJ
    Farm Hosp; 2020 Jan; 44(1):26-31. PubMed ID: 31901059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacist's role in chimeric antigen receptor T cell therapy.
    Booth JP; Kusoski CL; Kennerly-Shah JM
    J Oncol Pharm Pract; 2020 Oct; 26(7):1725-1731. PubMed ID: 32819199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Integration of a hospital pharmacist in the ICU].
    Moch C; Pivot C; Floccard B; Rimmelé T; Paillet C
    Ann Pharm Fr; 2014 Mar; 72(2):90-4. PubMed ID: 24630309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementation and operational management of marketed chimeric antigen receptor T cell (CAR-T Cell) therapy-a guidance by the GoCART Coalition Pharmacist Working Group.
    Nezvalova-Henriksen K; Langebrake C; Bauters T; Moreno-Martinez ME; Ahnfelt E; Ekelund H; Domingos V; Pires V; Bonnin A; Bojanić I; Cabrerizo Y; Terwel S; Tam A
    Bone Marrow Transplant; 2023 Oct; 58(10):1069-1074. PubMed ID: 37528237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-CD123 chimeric antigen receptor T-cells (CART): an evolving treatment strategy for hematological malignancies, and a potential ace-in-the-hole against antigen-negative relapse.
    Cummins KD; Gill S
    Leuk Lymphoma; 2018 Jul; 59(7):1539-1553. PubMed ID: 28901790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Roles of the hospital pharmacist and the cooperation between hospital pharmacy and insurance pharmacy in the introduction of home parenteral nutrition].
    Kawakami N; Ichiro N
    Gan To Kagaku Ryoho; 2004 Dec; 31 Suppl 2():182-4. PubMed ID: 15645766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes to supervision in community pharmacy: pharmacist and pharmacy support staff views.
    Bradley F; Schafheutle EI; Willis SC; Noyce PR
    Health Soc Care Community; 2013 Nov; 21(6):644-54. PubMed ID: 23718766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of clinical pharmacists in the emergency department of an Australian public hospital: A before and after study.
    Proper JS; Wong A; Plath AE; Grant KA; Just DW; Dulhunty JM
    Emerg Med Australas; 2015 Jun; 27(3):232-8. PubMed ID: 25818918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmaceutical counseling: Between evidence-based medicine and profits.
    Egorova SN; Akhmetova T
    Int J Risk Saf Med; 2015; 27 Suppl 1():S87-8. PubMed ID: 26639727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.